Copyright Hubei Longxiang Pharmaceutical Technology Co., Ltd. 鄂ICP备05005680号-1 Powered by www.300.cn
Warm congratulations on the successful listing of our company on the successful listing of "New Third Board"
On February 22, 2017, Hubei Longxiang Pharmaceutical Science and Technology Co., Ltd. was formally listed on the “New Three Boards” of the national small and medium-sized enterprise equity transfer system. The stock code was 871082, which became another important milestone in the history of the company's development.
The “New Third Board” is the third national securities exchange approved by the State Council following the Shanghai and Shenzhen Stock Exchanges and is part of a mature multi-tiered capital market. The “New Third Board” is mainly for the development of innovative, entrepreneurial, growth, and small and medium-sized enterprises.
Since its establishment, the company has been committed to protecting the industry and has achieved outstanding performance in the industry. To further advance, through the strong support of the Group's leadership, the company's all colleagues and all partners have made concerted efforts. Longxiang Pharmaceutical finally ushered in the rapids at this moment and officially entered the capital market.
The company will use this listing as an opportunity to make full use of the capital market's strength in marketing innovation, market development and other aspects to achieve a comprehensive and rapid development, in the future development will be more stringent requirements of standardized management, and effectively improve the level of operation and management.
Thousands of miles. Start with one step. The successful listing of the “new three boards” has opened up a new journey for Longxiang Pharmaceuticals. The company will repay the society with more high-quality products and services, reward shareholders with more outstanding performance, and create a first-class service brand. Development.